| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.9 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.9 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.0099 | 0.9 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.0094 | 0.9 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.031 | 0.9 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.05 | 0.9 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.9 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |